Picture of Diamyd Medical AB logo

DMYD B Diamyd Medical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Diamyd Medical: South Korea To Grant Precision Medicine Patent

Jan 21 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * SOUTH KOREA TO GRANT PRECISION MEDICINE PATENT TO DIAMYD
MEDICAL
FOR INSULIN ANTIGEN TREATMENT IN AUTOIMMUNE DIABETES
    * THIS PATENT, VALID UNTIL 2035
    * APPROVAL FURTHER ADVANCES FOUNDATION ESTABLISHED IN
PATIENTS
WITH HLA DR3-DQ2

Source text:  ID:nWkrb0W4TT 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Diamyd Medical AB

See all news